Efficacy and Safety of Ibrutinib in Indian Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Cases from a Named Patient Program.
Author | |
---|---|
Abstract | :
This named patient program evaluated the safety and efficacy of ibrutinib, a selective inhibitor of Bruton's tyrosine kinase in Indian patients with relapsed/refractory chronic lymphocytic leukemia (CLL, with/without chromosome 17 deletion [del17p]) and mantle cell lymphoma (MCL). |
Year of Publication | :
1969
|
Journal | :
Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
|
Volume | :
38
|
Issue | :
4
|
Number of Pages | :
508-515
|
Date Published | :
1969
|
ISSN Number | :
0971-5851
|
DOI | :
10.4103/ijmpo.ijmpo_43_17
|
Short Title | :
Indian J Med Paediatr Oncol
|
Download citation |